Published in Healthcare Mergers, Acquisitions and Ventures Week, July 17th, 2004
Also participating in the financing were Agilent Ventures and Versant Ventures.
"We are pleased to welcome an outstanding group of life sciences investors that supports and appreciates both our technology and our business model," stated Winnie H. Wan, PhD, chief executive officer of Aria Biosystems. "This financing allows us to complete the development of our first product and to advance our next two products."
Aria Biosystems' analytical tools are designed using optical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.